Results 11 to 20 of about 193,433 (305)
Over Ten-Year Kidney Graft Survival Determinants [PDF]
Kidney graft survival has been mainly evaluated using an up to 10-year threshold. Instead, in this study our aim was to evaluate predictive variables that impact long-term kidney graft survival (≥10 years).
Anabela Malho Guedes +8 more
doaj +2 more sources
Graft and patient survival in kidney transplantation: A single-center experience
Background: Patients with end-stage renal disease need renal replacement therapy, including hemodialysis, peritoneal dialysis, and kidney transplant (KT), to live a relatively normal life.
Chang-Hsu Chen +7 more
doaj +1 more source
Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats [PDF]
Early pregnancy factor (EPF), an extracellular chaperonin 10 homologue, has immunosuppressive and growth factor properties. In order to carry out more extensive studies on the in vivo characteristics of EPF, a recombinant form of the molecule has been ...
Murphy, R M +7 more
core +1 more source
An Antibody Combination That Targets Activated T Cells Extends Graft Survival in Sensitized Recipients [PDF]
Memory T cells are the very essence of adaptive immunity with their rapid and efficient response to antigen rechallenge and long-term persistence. However, it is becoming increasingly evident that when primed with self or transplanted tissue, these cells
Jurcevic, S.
core +1 more source
(A)Clear graft survival following keratoplasty is shown by Kaplan-Meier estimator. Treatment with miglyol (group 4) led to rejection at day 13 [12.5–13.5], whereas with AZM (group 3), no rejection was detected.
Philipp Eberwein (494900) +5 more
core +1 more source
Introduction: Delayed graft function (DGF) is a frequent complication after deceased donor kidney transplantation with an impact on the prognosis of the transplant.
Mateus Swarovsky Helfer +5 more
doaj +1 more source
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]
We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...
Mahendra, P +37 more
core +1 more source
BackgroundsInadequate liver volume and weight is a major source of morbidity and mortality after adult living donor liver transplantation (LDLT). The purpose of our study was to investigate HCC recurrence, graft failure, and patient survival according to
Jong Man Kim +5 more
doaj +1 more source
Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation. [PDF]
BACKGROUND Immunosuppressive therapies derived from solid organ transplantation are effective in promoting survival of vascularized composite allotransplantation (VCA), but they cause serious side effects that are difficult to justify for this non ...
Olariu, Radu +21 more
core +1 more source
Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting [PDF]
INTRODUCTION: Transplantation of neural stem cells (NSCs) is increasingly suggested to become part of future therapeutic approaches to improve functional outcome of various central nervous system disorders. However, recently it has become clear that only
Van Der Linden, Anne-Marie +24 more
core +1 more source

